BRCA1-related malignancies in a family presenting with von Recklinghausen's disease

被引:30
作者
Ceccaroni, M
Genuardi, M
Legge, F
Lucci-Cordisco, E
Carrara, S
D'Amico, F
Greggi, S
Scambia, G
机构
[1] Univ Sacred Heart, Dept Obstet & Gynecol, I-00168 Rome, Italy
[2] Univ Sacred Heart, Inst Med Genet, I-00168 Rome, Italy
[3] Univ Bologna, S Orsola Hosp, Dept Obstet & Gynecol, Bologna, Italy
关键词
neurofibromatosis; BRCA1; NF1; gynecologic malignancies; cancer risk; linkage analysis;
D O I
10.1006/gyno.2002.6757
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The association between neurofibromatosis and gynecologic malignancies is rarely reported in the literature. Both BRCA1 and NF1 genes are located on the long arm of chromosome 17. Case. We have observed a pedigree showing several individuals affected by both type 1 neurofibromatosis (NF1) and breast or coelomatic cancers. The number of individuals affected, their degree of relationship, and the early age at onset were suggestive of an hereditary breast/ovarian cancer syndrome. Linkage analysis was performed in order to establish whether markers in the chromosome 17 region containing the BRCA1 and NF1 loci were shared by affected individuals. Screening for BRCA1 mutations was performed by PTT and SSCP. Analysis of chromosome 17 DNA markers in the five family members tested show that three individuals affected by both NF1 and carcinomas share a common haplotype including the NF1 and BRCA1 loci on chromosome 17. Mutation analysis showed the presence of a nonsense mutation within BRCA1 exon 12 in two individuals, mother and daughter, affected by breast and peritoneal cancer, respectively, as well as in the son, who had rectal cancer at the early age of 27 years. All three subjects also had NF1. Conclusion. The concurrence of NF1 and hereditary breast ovarian cancer in this family is likely due to the presence of two linked mutations at the NF1 and BRCA1 loci. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:375 / 378
页数:4
相关论文
共 19 条
[1]  
BUDOWLE B, 1991, AM J HUM GENET, V48, P137
[2]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[3]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[4]   RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].
FORD, D ;
EASTON, DF ;
BISHOP, DT ;
NAROD, SA ;
GOLDGAR, DE ;
HAITES, N ;
MILNER, B ;
ALLAN, L ;
PONDER, BAJ ;
PETO, J ;
SMITH, S ;
STRATTON, M ;
LENOIR, GM ;
FEUNTEUN, J ;
LYNCH, H ;
ARASON, A ;
BARKARDOTTIR, R ;
EGILSSON, V ;
BLACK, DM ;
KELSELL, D ;
SPURR, N ;
DEVILEE, P ;
CORNELISSE, CJ ;
VARSEN, H ;
BIRCH, JM ;
SKOLNICK, M ;
SANTIBANEZKOREF, MS ;
TEARE, D ;
STEEL, M ;
PORTER, D ;
COHEN, BB ;
CAROTHERS, A ;
SMYTH, E ;
WEBER, B ;
NEWBOLD, B ;
BOEHNKE, M ;
COLLINS, FS ;
CANNONALBRIGHT, LA ;
GOLDGAR, D .
LANCET, 1994, 343 (8899) :692-695
[5]   Loss of heterozygosity in the region including the BRCA1 gene on 17q in colon cancer [J].
Garcia-Patiño, E ;
Gomendio, B ;
Lleonart, M ;
Silva, JM ;
Garcia, JM ;
Provencio, M ;
Cubedo, R ;
España, P ;
Cajal, SRY ;
Bonilla, F .
CANCER GENETICS AND CYTOGENETICS, 1998, 104 (02) :119-123
[6]   The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 [J].
Gutmann, DH ;
Aylsworth, A ;
Carey, JC ;
Korf, B ;
Marks, J ;
Pyeritz, RE ;
Rubenstein, A ;
Viskochil, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01) :51-57
[7]  
ISHIOKA C, 1995, ONCOGENE, V10, P841
[8]  
Korf B R, 2000, Oncologist, V5, P477, DOI 10.1634/theoncologist.5-6-477
[9]  
LENOIR GM, 1994, B ACAD NAT MED PARIS, V178, P123
[10]   SOMATIC MUTATIONS IN THE NEUROFIBROMATOSIS-1 GENE IN HUMAN TUMORS [J].
LI, Y ;
BOLLAG, G ;
CLARK, R ;
STEVENS, J ;
CONROY, L ;
FULTS, D ;
WARD, K ;
FRIEDMAN, E ;
SAMOWITZ, W ;
ROBERTSON, M ;
BRADLEY, P ;
MCCORMICK, F ;
WHITE, R ;
CAWTHON, R .
CELL, 1992, 69 (02) :275-281